U.S. Transfection Reagents & Equipment Market Size & Outlook
U.S. transfection reagents & equipment market, 2016-2028 (US$M)
Related Markets
U.S. transfection reagents & equipment market highlights
- The U.S. transfection reagents & equipment market generated a revenue of USD 307.5 million in 2020 and is expected to reach USD 584.6 million by 2028.
- The U.S. market is expected to grow at a CAGR of 8.4% from 2021 to 2028.
- In terms of segment, reagents was the largest revenue generating product in 2020.
- Equipment is the most lucrative product segment registering the fastest growth during the forecast period.
Transfection reagents & equipment market data book summary
| Market revenue in 2020 | USD 307.5 million |
| Market revenue in 2028 | USD 584.6 million |
| Growth rate | 8.4% (CAGR from 2020 to 2028) |
| Largest segment | Reagents |
| Fastest growing segment | Equipment |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Reagents, Equipment |
| Key market players worldwide | Thermo Fisher Scientific Inc, Lonza Group Ltd, Qiagen NV, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Merck KGaA, Origin Enterprises PLC, MaxCyte Inc, PromoCell GmbH, Promega, Polyplus-transfection, Horizon Discovery |
Other key industry trends
- In terms of revenue, U.S. accounted for 31.4% of the global transfection reagents & equipment market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In North America, U.S. transfection reagents & equipment market is projected to lead the regional market in terms of revenue in 2028.
- Canada is the fastest growing regional market in North America and is projected to reach USD 156.0 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Transfection Reagents & Equipment Market Scope
Transfection Reagents & Equipment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. transfection reagents & equipment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transfection reagents & equipment market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 54.41% in 2020. Horizon Databook has segmented the U.S. transfection reagents & equipment market based on reagents, equipment covering the revenue growth of each sub-segment from 2016 to 2028.
U.S transfection reagents and equipment market is expected to grow at a considerable rate in terms of revenue, owing to presence of molecular R&D laboratories and market players involved in development of advanced analytical technologies for transfection of hard-to-transfect cell lines.
Furthermore, increasing demand for gene expression methods to develop drugs for treatment of chronic infections is expected to impart significant potential in market growth. Players operating in the U.S. are expanding their product portfolio by launching unique reagents and protocols for efficient transfection of different cell lines.
Reasons to subscribe to U.S. transfection reagents & equipment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. transfection reagents & equipment market databook
-
Our clientele includes a mix of transfection reagents & equipment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. transfection reagents & equipment market , including forecasts for subscribers. This country databook contains high-level insights into U.S. transfection reagents & equipment market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. transfection reagents & equipment market size, by product, 2016-2028 (US$M)
U.S. Transfection Reagents & Equipment Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
